Researchers at iStopMM have for the first time described the prevalence of smoldering multiple myeloma and the findings indicate that it is present in 0.5%

Recently an interview appeared in Nordic Life Science with Thorir Long author of Defining new reference intervals for serum free light chains in individuals with

Sæmundur Rögnvaldsson a long-time member of the iStopMM core team defended his doctoral thesis Monoclonal gammopathy of what significance? Overcoming the methodological limitations of studying

We are proud to announce that a PhD student at the University of Iceland and a member of the iStopMM team Jón Þórir Óskarsson was

Sigurdur Yngvi Kristinsson professor of hematology at the University of Iceland Faculty of Medicine, specialist at Landspitali University Hospital and iStopMM´s principal investigator has been

The Multiple Myelome Hub has provided a good summary of the key talks and posters from the iStopMM team at the 63rd American Society of

Sigurður Yngvi Kristinsson, principal investigator of iStopMM, received a large project grant from the Icelandic Centre for Research (RANNIS) for the next three years for

In an article in CancerTherapyAdvisor.com the iStopMM study and it‘s results are covered. Results from the study were presented at the 2021 American Society of

Many of the planned studies from the iStopMM project use data on disease diagnoses in the Icelandic healthcare registries. In this paper published in the

In an article in OncLive experts specializing in multiple myeloma mention what they believe to be the top studies presented at the 2021 ASH annual